Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc. crawled date : 2021 - 09 - 20 save search
Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
VERU | $1.325 3.92% 3.77% 1.5M
|
Health Technology
|
| O: -4.25%
H: 3.62%
C: -1.17%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
prostate cancer phase 1 positive cancer phase 1b sabizabulin phase 2b
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
AADI | $1.79 -2.72% -2.79% 110K
|
Manufacturing
|
| O: -0.07%
H: 0.07%
C: -0.82%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.16%
H: 3.69%
C: 2.54%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
bioscience
Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
disease infectious disease test antiviral research
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.